5 Pharmaceutical Stocks to Buy Now

Advertisement

The grades of five pharmaceutical stocks are on the rise this week on Portfolio Grader. Each of these stocks is rated an “A” (“strong buy”) or “B” overall (“buy”).

NuPathe Inc. (PATH) is making progress this week as its rating of C (“hold”) from last week increases to a B (“buy”) rating this week. NuPathe develops pharmaceutical products used for the treatment and management of neurological and psychiatric diseases. In Portfolio Grader’s specific subcategories of Earnings Momentum and Earnings Revisions, PATH also gets A’s. For more information, get Portfolio Grader’s complete analysis of PATH stock.

This week, Actavis Plc (ACT) is showing good progress as the company’s rating jumps from a B (“buy”) last week to an A (“strong buy”). Actavis manufactures specialty pharmaceuticals. For more information, get Portfolio Grader’s complete analysis of ACT stock.

The rating of Watson Pharmaceuticals (WPI) moves up this week, rising from a B to an A. Watson develops, manufactures, markets, sells and distributes pharmaceutical products. For more information, get Portfolio Grader’s complete analysis of WPI stock.

Impax Laboratories, Inc.’s (IPXL) ratings are looking better this week, moving up to an A from last week’s B. Impax Laboratories develops, manufactures, and markets both proprietary and multi-source pharmaceutical products utilizing its drug delivery technologies. For more information, get Portfolio Grader’s complete analysis of IPXL stock.

Pacira Pharmaceuticals, Inc. (PCRX) is seeing ratings go up from a B last week to an A this week. Pacira Pharmaceuticals is a specialty pharmaceutical company with focuses on the development, commercialization, and manufacturing of proprietary pharmaceutical products. For more information, get Portfolio Grader’s complete analysis of PCRX stock.

Louis Navellier’s proprietary Portfolio Grader stock ranking system assesses roughly 5,000 companies every week based on a number of fundamental and quantitative measures. Stocks are given a letter grade based on their results — with A being “strong buy,” and F being “strong sell.” Explore the tool here.


Article printed from InvestorPlace Media, https://investorplace.com/2015/01/5-pharmaceutical-stocks-to-buy-now-path-act-wpi/.

©2024 InvestorPlace Media, LLC